StreetAlpha.app
Home › Stocks › SENS

Senseonics Holdings, Inc. (SENS)

Healthcare
$8.02
▼ −9.94%
LAST CLOSE · NOV 20

Senseonics makes Eversense, an implantable continuous glucose monitoring system for people with diabetes. It last closed at $8.02 on Nov 20, down 9.94% on the day. The next earnings report for SENS is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, SENS reported EPS of -$0.50 on revenue of $19.6M, with revenue up 141.6% from a year ago. Over its last 8 reports the stock moved an average of 13.8% the session after earnings. Over the last 12 months SENS insiders bought $627K of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is SENS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SENS.

Key Stats

Last 12 months
Results
Revenue
$60.0M
+104.8% vs a year ago
Net income
−$122.5M
−204.2% margin
EPS (diluted)
−$2.27
Free cash flow
−$114.0M
−190.0% margin
Valuation
Market cap
$439.3M
54.8M shares
P/E
–
No P/E while losing money
Price to sales
7.3
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$47.8M
At Sep 30
Debt
$54.2M
At Sep 30
Shareholder equity
$77.6M
Shares outstanding
54.8M
At Nov 3
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $1.4M$1.4MFY2021FY2022: $16.4M$16.4MFY2022FY2023: $22.4M$22.4MFY2023FY2024: $22.5M$22.5MFY2024FY2025: $35.3M$35.3MFY2025

From SENS's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · Time not announced
Reported EPS
-$0.50
Quarter ended Sep 2026
Year ago EPS
-$0.43
Same quarter last year
Revenue
$19.6M
+141.6% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.45Dec '24Mar 2025: -$0.40Mar '25Jun 2025: -$0.36Jun '25Sep 2025: -$0.43Sep '25Dec 2025: -$0.47Dec '25Mar 2026: -$0.71Mar '26Jun 2026: -$0.63Jun '26Sep 2026: -$0.50Sep '26Latest -$0.50
Revenue by quarter
Dec 2024: $8.3MDec '24Mar 2025: $6.3MMar '25Jun 2025: $6.6MJun '25Sep 2025: $8.1MSep '25Dec 2025: $14.3MDec '25Mar 2026: $11.7MMar '26Jun 2026: $14.5MJun '26Sep 2026: $19.6MSep '26Latest $19.6M
How SENS moved after its last 8 reports
Average move the session after a report ±13.8%
Nov 9, 2026After the close+2.4%
Aug 6, 2026After the close+36.3%
May 1, 2026Time not announced−22.8%
Mar 2, 2026After the close−18.1%
Jan 12, 2026Time not announced−1.5%
Nov 5, 2025After the close−7.6%
Oct 6, 2025After the close−16.9%
Aug 6, 2025After the close−4.9%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on SENSStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on SENS
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on SENS

Technical Analysis

SENS · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend

The stock is 16% below its 20 day and 15% below its 50 day average. It is 8% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the swing low (Nov 6) at $7.83, and the nearest resistance the 100 day average at $8.11.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 13.1%/day
Key levels
$13.9852 week high+74.3%
$9.3220 day average+16.2%
$9.2250 day average+15.0%
$8.67Pivot R1+8.1%
$8.40Swing high (Oct 20)+4.7%
$8.30Pivot+3.5%
$8.11100 day average+1.1%
$8.02Last close
$7.83Swing low (Nov 6)−2.4%
$7.65Pivot S1−4.6%
$7.37200 day average−8.1%
$4.7952 week low−40.3%
Indicators
RSI (14)40.59Middle of its rangeNeutral
MACD0.14Below its signal lineBearish
Stochastic17.2Near the bottom of its rangeOversold
ADX (14)29.9Trending up
Williams %R-96.9Oversold below −80, overbought above −20Oversold
CCI (20)-93.0Oversold below −100, overbought above 100Neutral
Rate of change−6.6%Change over 10 sessionsBearish
ATR (14)$1.05Typical daily range, 13.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for SENS

What happened before

See how SENS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow SENS usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How SENS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2016.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for SENSHow many large options trades hit SENS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

SENS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲75 buying vs 46 selling
  • ▲Held by funds +5.1 pts
  • ▲Funds holding +15
  • ▲Superinvestors: 3 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding128113+13.3%
In funds' top 1010–
Held by funds43.1%38.1%+5.1 pts
New / increased35 / 4041 / 31+4.2%
Reduced / sold out26 / 2016 / 18+35.3%
Put/call ratio0.01––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SENS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

SENS Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$627K5 buys · 2 insiders
Sold$00 sales · 0 insiders
Cluster buy: 2 insiders bought $200K between Mar 13 and Mar 13.
2026-03 bought $200K2026-05 bought $126K2026-08 bought $125K2026-11 bought $176KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 13Douglas A RoederDirectorBuy17,041$10.32$176K
Aug 19Douglas A RoederDirectorBuy13,953$8.98$125K
May 12Douglas A RoederDirectorBuy22,686$5.56$126K
Mar 13Douglas A RoederDirectorBuy17,500$5.73$100K
Mar 13Timothy T GoodnowPresident and CEOBuy17,225$5.79$100K
Nov 10, 2025Edelman StevenDirectorBuy10,000$6.55$66K
Every insider buy and sale for SENS over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See SENS insider trades →

From SEC Form 4 filings by SENS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SENS is in one of them and how their past SENS trades turned out.

SENS in the AI portfolios
Loading…

SENS News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SENS in an article yet. Here's the latest on the wider market.

SENS in the news

About Senseonics Holdings

Senseonics is a medical technology company that makes Eversense, an implantable continuous glucose monitoring system for people with diabetes. A small sensor is placed under the skin and works with a rechargeable transmitter and a phone app to track glucose levels for up to a year. The company sells the system to people with diabetes and to the healthcare providers who treat them, and it works with distribution partners in some markets. It is based in Germantown, Maryland.

Headquarters
Germantown, MD
Founded
1996